227 related articles for article (PubMed ID: 25959758)
1. [Metformin and left ventricular remodeling after acute myocardial infarction: molecular mechanisms and clinical implications].
Paneni F; Costantino S; Cosentino F
G Ital Cardiol (Rome); 2015 Apr; 16(4):225-31. PubMed ID: 25959758
[TBL] [Abstract][Full Text] [Related]
2. Metformin in non-diabetic patients presenting with ST elevation myocardial infarction: rationale and design of the glycometabolic intervention as adjunct to primary percutaneous intervention in ST elevation myocardial infarction (GIPS)-III trial.
Lexis CP; van der Horst IC; Lipsic E; van der Harst P; van der Horst-Schrivers AN; Wolffenbuttel BH; de Boer RA; van Rossum AC; van Veldhuisen DJ; de Smet BJ;
Cardiovasc Drugs Ther; 2012 Oct; 26(5):417-26. PubMed ID: 22968678
[TBL] [Abstract][Full Text] [Related]
3. Effect of metformin on left ventricular function after acute myocardial infarction in patients without diabetes: the GIPS-III randomized clinical trial.
Lexis CP; van der Horst IC; Lipsic E; Wieringa WG; de Boer RA; van den Heuvel AF; van der Werf HW; Schurer RA; Pundziute G; Tan ES; Nieuwland W; Willemsen HM; Dorhout B; Molmans BH; van der Horst-Schrivers AN; Wolffenbuttel BH; ter Horst GJ; van Rossum AC; Tijssen JG; Hillege HL; de Smet BJ; van der Harst P; van Veldhuisen DJ;
JAMA; 2014 Apr; 311(15):1526-35. PubMed ID: 24687169
[TBL] [Abstract][Full Text] [Related]
4. The cardioprotective effects of metformin.
El Messaoudi S; Rongen GA; de Boer RA; Riksen NP
Curr Opin Lipidol; 2011 Dec; 22(6):445-53. PubMed ID: 21897229
[TBL] [Abstract][Full Text] [Related]
5. Metformin improves cardiac function in rats via activation of AMP-activated protein kinase.
Wang XF; Zhang JY; Li L; Zhao XY; Tao HL; Zhang L
Clin Exp Pharmacol Physiol; 2011 Feb; 38(2):94-101. PubMed ID: 21143620
[TBL] [Abstract][Full Text] [Related]
6. Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling.
Calvert JW; Gundewar S; Jha S; Greer JJ; Bestermann WH; Tian R; Lefer DJ
Diabetes; 2008 Mar; 57(3):696-705. PubMed ID: 18083782
[TBL] [Abstract][Full Text] [Related]
7. Effect of Metformin on Metabolites and Relation With Myocardial Infarct Size and Left Ventricular Ejection Fraction After Myocardial Infarction.
Eppinga RN; Kofink D; Dullaart RP; Dalmeijer GW; Lipsic E; van Veldhuisen DJ; van der Horst IC; Asselbergs FW; van der Harst P
Circ Cardiovasc Genet; 2017 Feb; 10(1):. PubMed ID: 28100626
[TBL] [Abstract][Full Text] [Related]
8. Leukocyte telomere length and left ventricular function after acute ST-elevation myocardial infarction: data from the glycometabolic intervention as adjunct to primary coronary intervention in ST elevation myocardial infarction (GIPS-III) trial.
Haver VG; Hartman MH; Mateo Leach I; Lipsic E; Lexis CP; van Veldhuisen DJ; van Gilst WH; van der Horst IC; van der Harst P
Clin Res Cardiol; 2015 Oct; 104(10):812-21. PubMed ID: 25840550
[TBL] [Abstract][Full Text] [Related]
9. Metformin improves cardiac function in a nondiabetic rat model of post-MI heart failure.
Yin M; van der Horst IC; van Melle JP; Qian C; van Gilst WH; Silljé HH; de Boer RA
Am J Physiol Heart Circ Physiol; 2011 Aug; 301(2):H459-68. PubMed ID: 21572014
[TBL] [Abstract][Full Text] [Related]
10. Early short-term doxycycline therapy in patients with acute myocardial infarction and left ventricular dysfunction to prevent the ominous progression to adverse remodelling: the TIPTOP trial.
Cerisano G; Buonamici P; Valenti R; Sciagrà R; Raspanti S; Santini A; Carrabba N; Dovellini EV; Romito R; Pupi A; Colonna P; Antoniucci D
Eur Heart J; 2014 Jan; 35(3):184-91. PubMed ID: 24104875
[TBL] [Abstract][Full Text] [Related]
11. Activation of AMP-activated protein kinase by metformin improves left ventricular function and survival in heart failure.
Gundewar S; Calvert JW; Jha S; Toedt-Pingel I; Ji SY; Nunez D; Ramachandran A; Anaya-Cisneros M; Tian R; Lefer DJ
Circ Res; 2009 Feb; 104(3):403-11. PubMed ID: 19096023
[TBL] [Abstract][Full Text] [Related]
12. The Effect of Metformin on Diastolic Function in Patients Presenting with ST-Elevation Myocardial Infarction.
Al Ali L; Hartman MT; Lexis CP; Hummel YM; Lipsic E; van Melle JP; van Veldhuisen DJ; Voors AA; van der Horst IC; van der Harst P
PLoS One; 2016; 11(12):e0168340. PubMed ID: 27977774
[TBL] [Abstract][Full Text] [Related]
13. Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study.
Woo JS; Kim W; Ha SJ; Kim JB; Kim SJ; Kim WS; Seon HJ; Kim KS
Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2252-60. PubMed ID: 23868944
[TBL] [Abstract][Full Text] [Related]
14. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial.
Ibanez B; Macaya C; Sánchez-Brunete V; Pizarro G; Fernández-Friera L; Mateos A; Fernández-Ortiz A; García-Ruiz JM; García-Álvarez A; Iñiguez A; Jiménez-Borreguero J; López-Romero P; Fernández-Jiménez R; Goicolea J; Ruiz-Mateos B; Bastante T; Arias M; Iglesias-Vázquez JA; Rodriguez MD; Escalera N; Acebal C; Cabrera JA; Valenciano J; Pérez de Prado A; Fernández-Campos MJ; Casado I; García-Rubira JC; García-Prieto J; Sanz-Rosa D; Cuellas C; Hernández-Antolín R; Albarrán A; Fernández-Vázquez F; de la Torre-Hernández JM; Pocock S; Sanz G; Fuster V
Circulation; 2013 Oct; 128(14):1495-503. PubMed ID: 24002794
[TBL] [Abstract][Full Text] [Related]
15. Chronic treatment with metformin suppresses toll-like receptor 4 signaling and attenuates left ventricular dysfunction following myocardial infarction.
Soraya H; Clanachan AS; Rameshrad M; Maleki-Dizaji N; Ghazi-Khansari M; Garjani A
Eur J Pharmacol; 2014 Aug; 737():77-84. PubMed ID: 24842192
[TBL] [Abstract][Full Text] [Related]
16. Metformin attenuates ventricular hypertrophy by activating the AMP-activated protein kinase-endothelial nitric oxide synthase pathway in rats.
Zhang CX; Pan SN; Meng RS; Peng CQ; Xiong ZJ; Chen BL; Chen GQ; Yao FJ; Chen YL; Ma YD; Dong YG
Clin Exp Pharmacol Physiol; 2011 Jan; 38(1):55-62. PubMed ID: 21083698
[TBL] [Abstract][Full Text] [Related]
17. Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction study (REPAIR-AMI) cardiac magnetic resonance imaging substudy.
Dill T; Schächinger V; Rolf A; Möllmann S; Thiele H; Tillmanns H; Assmus B; Dimmeler S; Zeiher AM; Hamm C
Am Heart J; 2009 Mar; 157(3):541-7. PubMed ID: 19249426
[TBL] [Abstract][Full Text] [Related]
18. Effect of Intracoronary Metformin on Myocardial Infarct Size in Swine.
Techiryan G; Weil BR; Palka BA; Canty JM
Circ Res; 2018 Sep; 123(8):986-995. PubMed ID: 30355033
[TBL] [Abstract][Full Text] [Related]
19. Predicting chronic left ventricular dysfunction 90 days after ST-segment elevation myocardial infarction: An Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Substudy.
Ezekowitz JA; Armstrong PW; Granger CB; Theroux P; Stebbins A; Kim RJ; Patel MR
Am Heart J; 2010 Aug; 160(2):272-8. PubMed ID: 20691832
[TBL] [Abstract][Full Text] [Related]
20. Effect of Metformin Treatment on Lipoprotein Subfractions in Non-Diabetic Patients with Acute Myocardial Infarction: A Glycometabolic Intervention as Adjunct to Primary Coronary Intervention in ST Elevation Myocardial Infarction (GIPS-III) Trial.
Eppinga RN; Hartman MH; van Veldhuisen DJ; Lexis CP; Connelly MA; Lipsic E; van der Horst IC; van der Harst P; Dullaart RP
PLoS One; 2016; 11(1):e0145719. PubMed ID: 26808474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
